{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:21:11Z","timestamp":1761621671754,"version":"3.38.0"},"reference-count":27,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1684\/ejd.2018.3492","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:17:25Z","timestamp":1696864645000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI)"],"prefix":"10.1684","volume":"29","author":[{"given":"Maurice","family":"Jordan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ghoreschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska Carola","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"3492_CR1","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/jid.2013.134","volume":"133","author":"SC Flohil","year":"2013","unstructured":"Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971\u20138.","journal-title":"J Invest Dermatol"},{"key":"3492_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdv.12102","volume":"28","author":"I Schaefer","year":"2014","unstructured":"Schaefer I, Augustin M, Spehr C, Reusch M, Kornek T. Prevalence and risk factors of actinic keratoses in Germany-analysis of multisource data. J Eur Acad Dermatol Venereol 2014; 28: 309\u201313.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1067\/mjd.2000.103339","volume":"42","author":"RG Glogau","year":"2000","unstructured":"Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000;42: 23\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"3492_CR4","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1111\/jdv.13180","volume":"29","author":"RN Werner","year":"2015","unstructured":"Werner RN, Stockfleth E, Connolly SM, et al. Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short version. J Eur Acad Dermatol Venereol 2015; 29: 2069\u201379.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/jdv.14375","volume":"31","author":"P Arenberger","year":"2017","unstructured":"Arenberger P, Arenbergerova M. New and current preventive treatment options in actinic keratosis. J Eur Acad Dermatol Venereol 2017; 31: 13\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR6","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1111\/jdv.13076","volume":"29","author":"MC Fargnoli","year":"2015","unstructured":"Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K. Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy. J Eur Acad Dermatol Venereol 2015; 29: 1926\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/bjd.13138","volume":"171","author":"DM Rubel","year":"2014","unstructured":"Rubel DM, Spelman L, Murrell DF, et al. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol 2014; 171: 1164\u201371.","journal-title":"Br J Dermatol"},{"key":"3492_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/jdv.14177","volume":"31","author":"E Sotiriou","year":"2017","unstructured":"Sotiriou E, Apalla Z, Vrani F, et al. Daylight photodynamic therapy vs. conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra-individual comparison study. J Eur Acad Dermatol Venereol 2017; 31: 1303\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jdv.14613","volume":"32","author":"E Sotiriou","year":"2018","unstructured":"Sotiriou E, Evangelou G, Papadavid E, et al. Conventional vs. daylight photodynamic therapy for patients with actinic keratosis on face and scalp: 12-month follow-up results of a randomized, intra-individual comparative analysis. J Eur Acad Dermatol Venereol 2018; 32: 595\u2013600.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/jdv.14267","volume":"31","author":"T Dirschka","year":"2017","unstructured":"Dirschka T, Pellacani G, Micali G, et al. A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severityindex. J Eur Acad Dermatol Venereol 2017; 31: 1295\u2013302.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR11","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/jdv.14682","volume":"32","author":"L Schmitz","year":"2018","unstructured":"Schmitz L, Gambichler T, Gupta G, Stucker M, Dirschka T. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma. J Eur Acad Dermatol Venereol 2018; 32: 752\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pdpdt.2017.10.007","volume":"21","author":"L Schmitz","year":"2018","unstructured":"Schmitz L, von Dobbeler C, Gupta G, et al. Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI). Photodiagnosis Photodyn Ther 2018; 21: 66\u201370.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"3492_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","volume":"24","author":"EA Olsen","year":"1991","unstructured":"Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738\u201343.","journal-title":"J Am Acad Dermatol"},{"key":"3492_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13555-016-0145-2","volume":"6","author":"RM Szeimies","year":"2016","unstructured":"Szeimies RM, Atanasov P, Bissonnette R. Use of lesion response rate in actinic keratosis trials. Dermatol Ther (Heidelb) 2016; 6: 461\u20134.","journal-title":"Dermatol Ther (Heidelb)"},{"doi-asserted-by":"crossref","unstructured":"Skov T, Stockfleth E, Szeimies RM, Berman B. Efficacy endpoints in clinical trials in actinic keratosis. Dermatol Ther (Heidelb) 2018: 1\u20139.","key":"3492_CR15","DOI":"10.1007\/s13555-018-0247-0"},{"key":"3492_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/dth.12334","volume":"29","author":"G Genovese","year":"2016","unstructured":"Genovese G, Fai D, Fai C, Mavilia L, Mercuri SR. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis. Dermatol Ther 2016; 29: 191\u20136.","journal-title":"Dermatol Ther"},{"key":"3492_CR17","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/jdv.13228","volume":"29","author":"JP Lacour","year":"2015","unstructured":"Lacour JP, Ulrich C, Gilaberte Y, et al. Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe. J Eur Acad Dermatol Venereol 2015; 29: 2342\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1365-2133.2012.10833.x","volume":"166","author":"SR Wiegell","year":"2012","unstructured":"Wiegell SR, Fabricius S, Gniadecka M, et al. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327\u201332.","journal-title":"Br J Dermatol"},{"key":"3492_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2011.10209.x","volume":"164","author":"SR Wiegell","year":"2011","unstructured":"Wiegell SR, Fabricius S, Stender IM, et al. A randomized, multi-centre study of directed daylight exposure times of 1(1\/2) vs. 2(1\/2) h in daylight-mediated photodynamic therapy with methyl aminolae-vulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083\u201390.","journal-title":"Br J Dermatol"},{"key":"3492_CR20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1365-2133.2009.09119.x","volume":"160","author":"SR Wiegell","year":"2009","unstructured":"Wiegell SR, Haedersdal M, Eriksen P, Wulf HC. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308\u201314.","journal-title":"Br J Dermatol"},{"key":"3492_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/bjd.16559","volume":"179","author":"G Pellacani","year":"2018","unstructured":"Pellacani G, Gupta G, Micali G, et al. Actinic keratosis area severity index (AKASI): reproducibility study and comparison with total lesion count. Br J Dermatol 2018; 179: 763\u20134.","journal-title":"Br J Dermatol"},{"key":"3492_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bjd.13420","volume":"172","author":"C Kellner","year":"2015","unstructured":"Kellner C, Bauriedl S, Hollstein S, Reinhold U. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study. Br J Dermatol 2015; 172: 1146\u20138.","journal-title":"Br J Dermatol"},{"key":"3492_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bjd.13924","volume":"174","author":"N Neittaanmaki-Perttu","year":"2016","unstructured":"Neittaanmaki-Perttu N, Gronroos M, Karppinen TT, Tani TT, Snellman E. Hexyl-5-aminolaevulinate 0.2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial. Br J Dermatol 2016; 174: 427\u20139.","journal-title":"Br J Dermatol"},{"key":"3492_CR24","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/bjd.13326","volume":"171","author":"N Neittaanmaki-Perttu","year":"2014","unstructured":"Neittaanmaki-Perttu N, Karppinen TT, Gronroos M, Tani TT, Snellman E. Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate. Br J Dermatol 2014; 171: 1172\u201380.","journal-title":"Br J Dermatol"},{"key":"3492_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2340\/00015555-2484","volume":"97","author":"N Neittaanmaki-Perttu","year":"2017","unstructured":"Neittaanmaki-Perttu N, Karppinen TT, Tani T, Snellman E, Gronroos M. Long-term outcome of low-concentration hexyl-5-aminolaevulinate daylight photodynamic therapy for treatment of actinic keratoses. Acta Derm Venereol 2017; 97: 120\u20131.","journal-title":"Acta Derm Venereol"},{"key":"3492_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/jdv.14691","volume":"32","author":"MC Fargnoli","year":"2018","unstructured":"Fargnoli MC, Ibbotson SH, Hunger RE, et al. Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries. J Eur Acad Dermatol Venereol 2018; 32: 757\u201362.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3492_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s13555-017-0199-9","volume":"7","author":"JA See","year":"2017","unstructured":"See JA, Gebauer K, Wu JK, Manoharan S, Kerrouche N, Sullivan J. High patient satisfaction with daylight-activated methyl aminole-vulinate cream in the treatment of multiple actinic keratoses: results of an observational study in Australia. Dermatol Ther 2017; 7: 525\u201333.","journal-title":"Dermatol Ther"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2018.3492\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2018.3492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:21:31Z","timestamp":1741191691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2018.3492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2018.3492","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"21 August 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 Mai 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}